ZA96526B - Novel pharmaceutical formulation - Google Patents

Novel pharmaceutical formulation

Info

Publication number
ZA96526B
ZA96526B ZA96526A ZA96526A ZA96526B ZA 96526 B ZA96526 B ZA 96526B ZA 96526 A ZA96526 A ZA 96526A ZA 96526 A ZA96526 A ZA 96526A ZA 96526 B ZA96526 B ZA 96526B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
novel pharmaceutical
novel
formulation
pharmaceutical
Prior art date
Application number
ZA96526A
Other languages
English (en)
Inventor
Nils-Erik Anders Carlsson
Johan Georg Harmenberg
Bengt Goeran Hersloef
Ann Harriet Marg Kristofferson
Karl Stefan Lundquist
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA96526B publication Critical patent/ZA96526B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA96526A 1995-02-06 1996-01-23 Novel pharmaceutical formulation ZA96526B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500112 1995-02-06

Publications (1)

Publication Number Publication Date
ZA96526B true ZA96526B (en) 1996-08-06

Family

ID=20396817

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96526A ZA96526B (en) 1995-02-06 1996-01-23 Novel pharmaceutical formulation

Country Status (18)

Country Link
US (1) US6068860A (fr)
EP (1) EP0809501A1 (fr)
JP (1) JPH11509515A (fr)
KR (1) KR19980701958A (fr)
AR (1) AR002274A1 (fr)
AU (1) AU715212B2 (fr)
CA (1) CA2211409A1 (fr)
DZ (1) DZ1965A1 (fr)
FI (1) FI973230A0 (fr)
HR (1) HRP960033A2 (fr)
IL (1) IL116910A0 (fr)
MA (1) MA23799A1 (fr)
NO (1) NO973611L (fr)
NZ (1) NZ301406A (fr)
TN (1) TNSN96023A1 (fr)
WO (1) WO1996024359A1 (fr)
YU (1) YU7196A (fr)
ZA (1) ZA96526B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ1966A1 (fr) * 1995-02-06 2002-10-15 Astra Ab Combinaison pharmaceutique nouvelle.
FR2814071A1 (fr) * 2000-09-21 2002-03-22 Oreal Composition a base de glycoglyceride et ses utilisations notamment cosmetiques
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CN104117066B (zh) * 2014-07-16 2016-03-02 陈凌 外敷用抗甲状腺软膏的制备方法
US10759163B2 (en) 2014-10-27 2020-09-01 Hewlett-Packard Development Company, L.P. Printing device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009842B1 (fr) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposomes pour la libération d'agents pharmaceutiques et composition contenant un système d'agent pharmaceutique à liposome
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0249561B1 (fr) * 1986-06-12 1992-05-13 The Liposome Company, Inc. Compositions utilisant des médicaments anti-inflammatoires non-stéroides encapsulés dans des liposomes
WO1989005152A1 (fr) * 1987-12-09 1989-06-15 The Regents Of The University Of California Procede et composition anti-virale encapsulee dans des liposomes
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation

Also Published As

Publication number Publication date
NO973611L (no) 1997-09-26
WO1996024359A1 (fr) 1996-08-15
FI973230A7 (fi) 1997-08-05
AR002274A1 (es) 1998-03-11
NO973611D0 (no) 1997-08-05
YU7196A (sh) 1998-09-18
NZ301406A (en) 1999-01-28
MA23799A1 (fr) 1996-10-01
CA2211409A1 (fr) 1996-08-15
IL116910A0 (en) 1996-09-12
EP0809501A1 (fr) 1997-12-03
FI973230L (fi) 1997-08-05
JPH11509515A (ja) 1999-08-24
TNSN96023A1 (fr) 2005-03-15
AU4682096A (en) 1996-08-27
FI973230A0 (fi) 1997-08-05
DZ1965A1 (fr) 2002-07-17
HRP960033A2 (en) 1997-10-31
KR19980701958A (ko) 1998-06-25
AU715212B2 (en) 2000-01-20
US6068860A (en) 2000-05-30

Similar Documents

Publication Publication Date Title
GB9519363D0 (en) Pharmaceutical formulation
EG23826A (en) Pharmaceutical formulations
AP9600883A0 (en) Pharmaceutical formulations
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
HU9601698D0 (en) Pharmaceutical composition
EP0862431A4 (fr) Preparation pharmaceutique
IL112521A0 (en) Pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
GB9519667D0 (en) Pharmaceutical composition
GB9416599D0 (en) Pharmaceutical formulation
GB9523566D0 (en) Pharmaceutical formulation
ZA9610426B (en) Pharmaceutical composition
ZA961051B (en) Pharmaceutical composition
ZA96526B (en) Novel pharmaceutical formulation
ZA96392B (en) Pharmaceutical formulations
HU9602822D0 (en) Pharmaceutical composition
GB9500978D0 (en) Pharmaceutical formulations
GB9502786D0 (en) Pharmaceutical formulation
GB9525386D0 (en) Pharmaceutical formulation
HUP9602732A3 (en) Pharmaceutical composition comprising lanperisone
ZA95736B (en) Pharmaceutical composition
GB9516584D0 (en) Pharmaceutical formulations
GB9503752D0 (en) Pharmaceutical formulations
GB9508989D0 (en) Pharmaceutical formulations